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Abstract
Background: The neglected tropical diseases (NTDs) cause significant morbidity and mortality worldwide. Due to the
growth in international travel and immigration, NTDs may be diagnosed in countries of the western world, but there has
been no specific focus in the literature on imported NTDs.
Methods: Retrospective study of a cohort of immigrants and travelers diagnosed with one of the 13 core NTDs at a Tropical
Medicine Referral Unit in Spain during the period April 1989-December 2007. Area of origin or travel was recorded and
analyzed.
Results: There were 6168 patients (2634 immigrants, 3277 travelers and 257 VFR travelers) in the cohort. NTDs occurred
more frequently in immigrants, followed by VFR travelers and then by other travelers (p,0.001 for trend). The main NTDs
diagnosed in immigrants were onchocerciasis (n=240, 9.1%) acquired mainly in sub-Saharan Africa, Chagas disease (n=95,
3.6%) in immigrants from South America, and ascariasis (n=86, 3.3%) found mainly in immigrants from sub-Saharan Africa.
Most frequent NTDs in travelers were: schistosomiasis (n=43, 1.3%), onchocerciasis (n=17, 0.5%) and ascariasis (n=16,
0.5%), and all were mainly acquired in sub-Saharan Africa. The main NTDs diagnosed in VFR travelers were onchocerciasis
(n=14, 5.4%), and schistosomiasis (n=2, 0.8%).
Conclusions: The concept of imported NTDs is emerging as these infections acquire a more public profile. Specific issues
such as the possibility of non-vectorial transmission outside endemic areas and how some eradication programmes in
endemic countries may have an impact even in non-tropical western countries are addressed. Recognising NTDs even
outside tropical settings would allow specific prevention and control measures to be implemented and may create unique
opportunities for research in future.
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Introduction
The neglected tropical diseases (NTDs) are a group of mainly
chronic illnesses identified as causing considerable morbidity and
mortality typically amongst the world’s poorest populations and
which have also been shown to promote poverty [1]. The effect of
the NTDs as a group is such that they have been considered to be
part of a group of four, together with HIV/AIDS, tuberculosis
(TB) and malaria. NTDs cause over 500, 000 deaths annually and
have been estimated to result in a greater number of disability-
adjusted life years lost than malaria and tuberculosis [2,3].
Although in this sense many infections could be included, 13
core NTDs have been specifically targeted due to their prevalence
and the burden of disease they cause globally and they include
helminths, protozoa and tropical bacteria [1,2].
Experts have argued other infections, such as those caused by
arboviruses like dengue and yellow fever [4], and those caused by
helminths like Strongyloides sp [5], should also be included and this
will occur as efforts to control these diseases as a means to target
poverty continue to develop. In the year 2000, the Millennium
Declaration established goals to eliminate extreme poverty, hunger
and disease and specifically addressed the health and economic
impact of infectious diseases [1]. However, the NTDs remain
relatively unknown to the general public, partly as a consequence
of the decreased media coverage of these infections [6]. There has
also been decreased investment by the pharmaceutical companies
in new treatments for these conditions [7]. Recent increased efforts
and interest at the international level have focused on the diseases
mainly in endemic areas.
The growth in international travel and immigration which is
taking place currently is a well-known phenomenon, and NTDs are
nolongergeographically-restrictedasbothimmigrantsandtravelers
(including immigrants who travel to visit friends and relatives,
VFRs) in the western world may present with these infections. This
study focuses on imported NTDs from the perspective of a Tropical
Medicine Referral Unit in a European country which, with the
exception of leishmaniasis, is not endemic for these infections. To
date, there has been no significant focus in the literature on the
subject of NTDs as a group in immigrants and travelers, and no
specific studies on the emerging phenomenon of imported NTDs.
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Ethics statement
This was a retrospective analysis of data obtained over a 19-year
period, data were analyzed anonymously and written informed
consent was not obtained from individual participants. The
research was approved by the Ramo ´n y Cajal Hospital’s Ethics
Committee (Comite ´ Etico de Investigacio ´n Clı ´nica, CEIC,
Hospital Ramo ´n y Cajal).
A retrospective study of a cohort of 6168 patients (2634
immigrants, 3277 travelers and 257 VFRs- travelers visiting
friends and relatives) seen at a Tropical Medicine Referral Unit in
Madrid, Spain during the period April 1989 to December 2007
was performed. The unit is part of the Infectious Diseases
department of a large (.1200-bed) tertiary referral teaching
hospital and sees a large proportion of sub-Saharan immigrants
referred from a non-profit organization for African immigrants
based in Madrid as well as a large subset of Latin American
immigrants. In Spain, basic medical assistance is given to all the
population, national or foreign, and to both legal and illegal
immigrants. Patients need only to be in possession of a health card
to receive medical care. If there are difficulties in accessing this
health card (cultural/linguistic barriers), patients may be referred
from non-profit organizations.
A traveler was defined as any person who had crossed an
international border within 10 years before presentation and an
immigrant was defined as any person arriving in a country
different from their own with the objective of settling in the new
country. A VFR traveler was defined as any traveler (or their
children, even if they were born in Spain) who returned to their
country of origin for the purpose of visiting friends and relatives.
Screening for asymptomatic patients comprised blood count,
biochemistry, basic urinalysis, HIV, hepatitis B virus and hepatitis
C virus serology, rapid plasma reagin for syphilis, tuberculin skin
test, stool parasites, PCR for malaria in sub-Saharan Africans
(since 2005), and Trypanosoma cruzi serology (both immunofluores-
cent antibody test and ELISA) in Latin Americans. Other tests
were ordered according to specific symptoms and signs.
Cases were identified from a database of patients if they had
one or more of the 13 core NTDs (ascariasis, trichuriasis,
hookworm infection, schistosomiasis, lymphatic filariasis, tracho-
ma, onchocerciasis, leishmaniasis, Chagas disease, leprosy, human
African trypanosomiasis, dracunculiasis, Buruli ulcer) [1]. Gender,
age and country of origin/travel were recorded. Standard
diagnostic methods for each infection were used. A patient was
defined as having NTD polyparasitism if more than one NTD
was diagnosed. Positive epidemiological risk factors were
considered in immigrants from endemic areas for the infection
and if a traveler had visited an endemic area and had history of
exposure.
Cases of schistosomiasis, onchocerciasis and lymphatic filariasis
were classified as definite or probable cases based on the evidence
available as outlined below.
Ascariasis, trichuriasis, hookworm
Diagnoses based on finding typical parasite eggs on stool
examination (formol ether concentration method).
Schistosomiasis
Definite schistosomiasis in an immigrant was diagnosed after
identifying the parasite eggs in specimens (urine, stool or biopsy
specimens). Probable schistosomiasis in an immigrant was
diagnosed on finding positive serology in a patient with clinical
symptoms/signs of schistosomiasis (hematuria and/or eosinophil-
ia) or if there was documented response to treatment with
praziquantel (resolution of symptoms/signs and normal eosinophil
count) in a patient with clinical symptoms/signs of schistosomiasis
(hematuria and/or eosinophilia). Definite schistosomiasis in a
traveler was defined after identifying the parasite eggs in specimens
(urine, stool or biopsy specimens) or if history of exposure and
positive serology. Probable schistosomiasis in a traveler was
diagnosed if history of exposure and suggestive clinical signs/
symptoms (swimmer’s itch, Katayama fever or hematuria and/or
eosinophilia) or history of exposure, suggestive clinical symptoms/
signs and response to praziquantel (resolution of signs/symptoms
and normal eosinophil count).
Lymphatic filariasis
Diagnosis established on finding microfilariae after lysis-
centrifugation of night-time blood specimens. Probable cases of
lymphatic filariasis based on epidemiological risk factors, compat-
ible clinical symptoms/signs and response to treatment.
Onchocerciasis
Diagnosis of definite onchocerciasis in immigrants was based on
identification of Onchocerca volvulus microfilariae in ‘‘skin snips’’ or
clinical signs/symptoms of onchocerciasis (pruritus and/or skin
lesions suggestive of onchocerciasis) and a positive Mazzotti
provocation test with diethyl carbamazine (DEC) (symptoms
appearing after a single oral dose of 25–50 mg of DEC, performed
in patients with negative skin snips and no evidence of ocular
involvement). Probable onchocerciasis in an immigrant was
diagnosed if clinical signs/symptoms and response to treatment
with ivermectin (symptom resolution). Onchocerciasis (definite)
was diagnosed in a traveler when microfilariae were identified in
skin snips or if positive serology in a patient with clinical
symptoms/signs of onchocerciasis (pruritus/skin lesions suggestive
of onchocerciasis). Slit lamp examinations were performed in
patients with ocular symptoms or prior to the Mazzotti
provocation test.
Author Summary
Neglected Tropical Diseases (NTDs) have been targeted
due to their prevalence and the burden of disease they
cause globally, but there has been no significant focus in
the literature on the subject of NTDs as a group in
immigrants and travelers, and no specific studies on the
emerging phenomenon of imported NTDs. We present the
experience of a Tropical Medicine Unit in a major European
city, over a 19-year period, describing and comparing NTDs
diagnosed amongst immigrants, travelers and travelers
visiting friends and relatives (VFRs). NTDs were diagnosed
outside tropical areas and occurred more frequently in
immigrants, followed by VFR travelers and then by other
travelers. The main NTDs diagnosed in immigrants were
onchocerciasis, Chagas disease and ascariasis; most
frequent NTDs in travelers were schistosomiasis, oncho-
cerciasis and ascariasis, and onchocerciasis and schistoso-
miasis in VFRs. Issues focusing on modes of transmission
outside endemic areas and how eradication programs for
some NTDs in endemic countries may have an impact in
non-tropical Western countries by decreasing disease
burden in immigrants, are addressed. Adherence to basic
precautions such as safe consumption of food/water and
protection against arthropod bites could help prevent
many NTDs in travelers.
Imported Neglected Tropical Diseases
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Diagnosis based on identification of amastigotes in skin or bone
marrow biopsies, and/or positive culture results (Novy-McNeal-
Nicolle medium) and/or positive PCR results (Leishmania nested
PCR, LnPCR, of blood/bone marrow/skin biopsies)[8].
Chagas disease
T. cruzi infection was defined by positive serology using two
different techniques (ELISA and IFAT). For all patients with
Chagas disease, an ECG and echocardiogram were requested, and
upper/lower gastrointestinal barium studies or esophageal ma-
nometry were requested in patients with symptoms.
Leprosy
Cases were diagnosed on obtaining positive skin smears
(presence of Ziehl-Nielsen acid fast bacilli) in a patient with
clinical symptoms/signs of leprosy.
An SPSS 12.0 for Windows package (SPSS Inc., Chicago, USA)
was used to analyze the data.
Results
Out of 6168 patients, 2634 were immigrants, 3277 travelers and
257 were VFR travelers. In the group of immigrants there were
1567 males (59.5%) and 1067 females (40.5%). The mean age was
30 years (range: 1–83 yrs). The majority of immigrants were from
Central Africa (n=912, 34.6%), West Africa (n=843, 32.0%), and
South America (n=603, 22.9%). In the group of travelers there
were 1704 males (52.0%) and 1573 females (48.0%). The mean
age was 36 years (range: 21–80 yrs). The majority had traveled to
Central America and the Caribbean (n=620, 18.9%), West Africa
(n=509, 15.5%), and South America (n=508, 15.5%). In the
group of VFR travelers there were 123 males (47.9%) and 134
females (52.1%). The mean age was 36 years (range 1–73 yrs). The
majority had traveled to Central Africa (n=109, 42.4%), South
America (n=60, 23.3%) and West Africa (n=50, 19.5%). Patient
distribution according to world area of origin (for immigrants) or
world area of travel (for travelers and VFR travelers) is shown in
table 1. The number of NTDs diagnosed in immigrants, travelers
and VFR travelers during the study period is shown in table 2.
NTDs occurred more frequently in immigrants, followed by VFR
travelers and then by other travelers. This difference was found to
be statistically significant (chi-square test, p,0.001 for trend).
Soil-transmitted helminths
In total, 103 patients were diagnosed with ascariasis (86
immigrants, 16 travelers, and 1 VFR). Amongst the immigrants
there were 54 females and 32 males (mean age 24 years, range: 1–
74 yrs).Most patientswere from CentralAfrica[EquatorialGuinea
(68), Angola (3), Cameroon (1), and Central African Republic (1)],
followed by South America [Ecuador (6), Colombia (3)], and West
Africa [Liberia (2), Nigeria (2)]. There were eight male and eight
female travelers (mean age 32 years, range 23–80 yrs). The
majority had traveled to sub-Saharan Africa: Equatorial Guinea
(3), and one each to Congo D.R., Mozambique, Senegal, and
Cameroon. Other countries visited included: India (2), Ecuador (2),
Morocco (2), Algeria, Mexico, and Guatemala. One female VFR
traveler to E. Guinea was diagnosed with ascariasis.
All the patients diagnosed with trichuriasis were immigrants (47
females and 27 males, mean age 26 years, range: 1–73 yrs), the
majority from Central Africa [Equatorial Guinea (65), Angola (2),
Cameroon (1)] followed by Ecuador (2) and one each from Brazil,
Dominican Republic, Guatemala, and Liberia.
Out of 11 hookworm infections, nine occurred in immigrants
(five females, four males, mean age: 35 years, range: 9–69 yrs) and
two in travelers (both male, both aged 29 yrs). All the immigrants
were originally from Equatorial Guinea, and the travelers had
visited Senegal/Guinea Bissau and Thailand.
Table 1. Age, gender and patient distribution according to world area of origin or travel.
Immigrants n=2634
(% of total)
Travelers n=3277
(% of total)
VFR n=257
(% of total)
Mean age (years) 30 36 36
Gender (% male) 59.5% 52.0% 47.9%
World area of origin or travel:
Central Africa 912 (34.6%) 455 (13.9%) 109 (42.4%)
East Africa 52 (2.0%) 478 (14.6%) 5 (1.9%)
North Africa 53 (2.0%) 110 (3.4%) 3 (1.2%)
West Africa 843 (32.0%) 509 (15.5%) 50 (19.5%)
South Africa 3 (0.1%) 69 (2.1%) 0 (0%)
Central America/Caribbean 81 (3.1%) 620 (19.0%) 20 (7.8%)
North America 1 (,0.1%) 5 (0.2%) 1 (0.4%)
South America 603 (22.9%) 508 (15.5%) 60 (23.3%)
East Asia 9 (0.3%) 17 (0.5%) 0 (0%)
West and Southwest Asia 9 (0.3%) 33 (1.0%) 1 (0.4%)
Southcentral Asia 26 (1.0%) 287 (8.8%) 5 (1.9%)
Southeast Asia 7 (0.3%) 162 (4.9%) 3 (1.2%)
Oceania 1 (,0.1%) 14 (0.4%) 0 (0%)
Europe 31 (1.2%) 7 (0.2%) 0 (0%)
Not recorded 3 (0.1%) 3 (0.1%) 0 (0%)
doi:10.1371/journal.pntd.0000762.t001
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There were 28 immigrants diagnosed with schistosomiasis (13
definite and 15 probable cases), 26 males and two females (mean
age 25 years, range: 16–55 yrs). Out of the 13 definite cases, 8 had
S. haematobium and 5 had S. mansoni. The majority (26) of patients
were from sub-Saharan Africa. Patient distribution according to
country of origin was as follows: Equatorial Guinea (5), Mali (5),
Cameroon (3), Nigeria (3), Sierra Leone (2), Angola (2), Ghana (2),
Liberia (2), Niger (1), Republic of Guinea (1), Egypt (1), and
Ecuador (1). With respect to the main symptoms/signs: no patients
presented with acute symptoms, 18 (64.3%) had eosinophilia, and
13 (46.4%) had hematuria.
Out of 43 cases of schistosomiasis diagnosed in travelers, 19
were considered definite and 24 were probable cases, 23 were
male and 20 female (mean age 34 years, range 23–55 yrs). Out of
19 definite cases, 5 had S. haematobium and 14 were classified as
Schistosoma sp. (positive serology and history of exposure). For all
travelers, risk factors for acquisition of schistosomiasis were
identified (freshwater exposure in endemic countries), and a large
proportion of patients (19/43, 44.2%) had traveled to Mali. With
respect to main symptoms/signs: 7 patients (16.3%) referred
symptoms suggestive of acute schistosomiasis, 32 patients (74.4%)
had eosinophilia, and 17 (39.5%) had hematuria.
Only two cases were diagnosed amongst VFRs: one 53 year-old
female (Schistosoma sp., traveled to E. Guinea) and one35 year-old
male (S. haematobium, traveled to Cameroon) were diagnosed with
schistosomiasis.
Lymphatic filariasis
Two probable cases of lymphatic filariasis were identified
(microfilariae were not obtained from specimens but they had
suggestive clinical signs/symptoms and responded to treatment). A
60 year-old male immigrant from India presented with eosino-
philia, bilateral testicular hydrocele and prominent chyluria. A 52
year-old Spanish male who had worked in Equatorial Guinea for
2.5 years had presented with eosinophilia, bilateral lower limb
edema and a left testicular hydrocele.
Onchocerciasis
A total of 240 cases of onchocerciasis were identified in
immigrants. Of these, 169 cases were definite cases and 71 were
probable cases. There were 158 females and 82 males (mean age
33 years, range: 5–76 yrs). All but two of the cases of
onchocerciasis in immigrants occurred in African patients. The
majority of patients were from Equatorial Guinea (213/240,
88.8%), followed by Cameroon (6/240, 2.5%), Nigeria (4/240,
1.7%), Angola (4/240, 1.7%), Zaire (3/240, 1.3%) and one each
from Republic of Guinea, Mali, Togo, D.R. Congo, Ghana, Sierra
Leone, Sao Tome, Ivory Coast, Colombia, and Ecuador (1/240,
0.4%).
A linear regression analysis was performed taking into account
the number of new diagnoses of onchocerciasis (excluding two
patients from South America) and the number of new African
immigrants seen per year. A statistically significant decrease was
found in the number of cases of onchocerciasis diagnosed each
year at the unit (p,0.001; b 21.84, 95% C.I. 22.46 to 21.22)
(See figure 1).
There were 17 travelers (nine females and eight males, mean
age 37 years, range: 21–59 yrs) diagnosed with definite onchocer-
ciasis. Of these, 16 patients were long-term travelers, (trip duration
.3 months, range: 3–336 months) and 1 patient had traveled for 1
month. All patients had traveled to sub-Saharan Africa and
countries visited included: Equatorial Guinea, Angola, Cameroon,
DR of Congo, Ivory Coast, Burkina Faso, Central African
Republic and Mali. Some patients had visited more than one
country during their travel.
Amongst VFR travelers, 14 diagnoses of onchocerciasis were
made (5 males and 9 females, mean age 31 years, range: 6–
53 yrs), 12 had traveled to E. Guinea and 2 had traveled to
Cameroon.
Table 2. NTDs diagnosed in immigrants, travelers and VFRs (April 1989- December 2007).
NTD*
Total
n=6168
Immigrants
n=2634
(% of total)
Travelers
n=3277
(% of total)
VFR
n=257
(% of total)
Ascariasis 103 86 (3.3%) 16 (0.5%) 1 (0.4%)
Trichuriasis 74 74 (2.8%) 0 (0.0%) 0 (0%)
Hookworm infection 11 9 (0.3%) 2 (0.1%) 0 (0%)
Schistosomiasis 73 28 (1.1%) 43 (1.3%) 2 (0.8%)
Lymphatic filariasis 2 1 (,0.1%) 1 (,0.1%) 0 (0%)
Trachoma 0 0 (0.0%) 0 (0.0%) 0 (0%)
Onchocerciasis 271 240 (9.1%) 17 (0.5%) 14 (5.4%)
Leishmaniasis (cutaneous-mucocutaneous/visceral) 13/2 5/1 (0.2%) 8/1 (0.3%) 0 (0%)
Chagas disease 95 95 (3.6%) 0 (0.0%) 0 (0%)
Leprosy 10 9 (0.3%) 1 (,0.1%) 0 (0%)
Human African trypanosomiasis 0 0 (0.0%) 0 (0.0%) 0 (0%)
Dracunculiasis 0 0 (0.0%) 0 (0.0%) 0 (0%)
Buruli ulcer 0 0 (0.0%) 0 (0.0%) 0 (0%)
Total number of patients diagnosed with $1 NTD** 576 (9.3%) 476 (18.1%) 85 (2.6%) 15 (5.8%)
Total number of patients with .1 NTD (polyparasitised) 78 (1.3%) 72 (2.7%) 4 (0.1%) 2 (0.8%)
*Core neglected tropical diseases ranked by global prevalence (1).
**As each patient could have .1 diagnosis, the number of cases may be higher than the number of patients.
doi:10.1371/journal.pntd.0000762.t002
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Amongst the group of immigrants, there were three males and
three females (mean age: 34 years, range: 17–50 yrs). There were
three cases of cutaneous leishmaniasis (CL) (patients were from
Brazil, Algeria and Panama), two cases of mucocutaneous
leishmaniasis (ML) (from Bolivia and Ecuador) and one visceral
leishmaniasis (VL) (from Cameroon but had stayed in Northern
Africa for two years).
There were seven male and two female travelers (mean age: 37
years, range 28–55 years). CL was diagnosed in six (these travelers
had visited Costa Rica (n=2), Panama, French Guyana,
Colombia and India), ML in two (from Ecuador and Bolivia/
Peru) and VL in one patient (Peru).
Chagas disease
In total, 95 immigrants were diagnosed with Chagas disease: 62
females and 33 males, (mean age 36 years, range: 16–69 years).
The majority of patients were from Bolivia (90/95, 94.7%) and
one each from Brazil, Chile, Ecuador, Paraguay, and Honduras.
With regards to risk factors for acquisition of Chagas disease in
their countries of origin, 79 patients were from rural areas, 76
patients recalled having seen the vector in their homes in their
countries of origin, 15 patients had received a blood transfusion in
endemic countries and for 7 patients vertical transmission was a
possibility (mother with known positive T. cruzi serology). Not all
patients had completed their full work-up to ascertain degree of
visceral involvement during the study period: 16 patients were
found to have abnormalities on ECG (out of 68 tests performed)
and 10 had abnormalities on echocardiogram suggestive of
Chagas disease (out of 58 tests performed). Out of 36 esophageal
manometries and 44 barium enemas performed 4 in each group,
showed abnormalities suggestive of Chagas disease.
Leprosy
Nine immigrants were diagnosed with leprosy, five males and
four females (mean age 42 years, range: 24–64 yrs). Two patients
were from the Dominican Republic, two from Colombia, two
from Equatorial Guinea and one each from Mauritania, Brazil,
and the Philippines. Four patients had lepromatous leprosy, two
patients, tuberculoid leprosy, one patient, borderline-tuberculoid
leprosy, one had borderline-lepromatous leprosy and one had
borderline leprosy. The one traveler diagnosed with leprosy had
lived for nearly 60 years in Cuba (expatriate) and was diagnosed
with borderline-lepromatous leprosy.
There were no cases of trichuriasis, hookworm infection,
lymphatic filariasis, leishmaniasis, Chagas disease, or leprosy
diagnosed in VFR travelers.
Trachoma, human African trypanosomiasis,
dracunculiasis, Buruli ulcer
No cases were diagnosed in this series.
NTD polyparasitism
Some patients were diagnosed with more than one NTD (with a
maximum of 2 NTDs per patient): 72 immigrants, 4 travelers and
2 VFR travelers.
Figure 1. Linear regression analysis: number of new cases of onchocerciasis per new African patients seen at the unit each year.
p,0.001; b 21.84 (95% C.I. 22.46 to 21.22).
doi:10.1371/journal.pntd.0000762.g001
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infection and ascariasis (both from E. Guinea), 3 were diagnosed
with hookworm and trichuriasis (all from E. Guinea), 8 were
diagnosed with ascariasis and onchocerciasis (all from E. Guinea),
49 were diagnosed with ascariasis and trichuriasis (44 from E.
Guinea, 2 from Ecuador and one each from Liberia, Angola and
Cameroon), 1 patient was diagnosed with CL and trichuriasis
(from Brazil), 2 with leprosy and onchocerciasis (from E. Guinea)
and 7 with onchocerciasis and trichuriasis (all from E. Guinea).
In the group of travelers, 1 patient was diagnosed with
hookworm and ascariasis (travel to Brazil for 25 days), 1 patient
with ascariasis and onchocerciasis (travel to Cameroon for 6
months), and 2 patients were diagnosed with onchocerciasis and
schistosomiasis (travel to Central African Republic for 5months
and the other patient had traveled to Burkina Faso and Ivory
Coast for 1 month).
In the group of VFR travelers, 2 patients were diagnosed with
schistosomiasis and onchocerciasis. These patients had traveled to
Cameroon and Equatorial Guinea for 15 days and 2 months,
respectively.
NTD polyparasitism was most frequent amongst immigrants,
followed by VFR travelers and then by other travelers, respectively
(p,0.001 for trend).
Discussion
NTDs are acquiring a more public profile, and in parallel the
concept of imported NTDs, is also emerging. As demonstrated,
NTDs are not restricted to the tropics, and may be diagnosed in
countries of the developed world in travelers, immigrants and
VFRs.
Certain limitations of the study, such as the under-representa-
tion of patients from Asia, Oceania and North America, may not
allow extrapolation of all results to other groups of travelers and
immigrants.
Some patients were lost to follow-up reflecting the mobile
nature and difficulty of access to health services of both
immigrants (illegal residents were also included in the study) and
travelers. This may have led to an underestimation of the
frequency of NTDs in this group, especially if loss of follow-up
implied a diagnosis was not reached. However, the large sample
size and the length of the study period add strength to the study,
and highlight some important issues.
NTDs manifesting in endemic areas and imported NTDs will
share certain features but differences may also be expected. The
spectrum and frequency of diseases diagnosed in endemic and
non-endemic areas may differ. Disease burden may be lower when
the infections occur outside endemic areas. Although the number
of patients traveling with pre-existing medical conditions is
increasing [9], a large proportion of travelers are healthy and in
the same way an important proportion of immigrants who seek
work opportunities and who are able to travel to do so, would
generally be expected to be in good health. The occurrence of an
NTD in a healthy person should not have the same devastating
effects as those observed in endemic areas, where infections and
re-infection with multiple NTDs are not infrequent and worsen
the burden of disease.
Populations in endemic regions can be infected with multiple
neglected tropical diseases [10] and this was also observed with
imported NTDs. As would be expected due to the greater risk and
length of exposure, NTD polyparasitism was most frequent
amongst immigrants, followed by VFR travelers and other
travelers, respectively, and this difference was statistically signif-
icant for trend. The most frequent cause of polyparasitism in this
series was due to coinfection with one of the geohelminths
(ascariasis, trichuriasis, and hookworm), reflecting the large burden
of disease caused by these parasites worldwide [1].
There were few cases of NTDs amongst VFR travelers, who as
a group accounted for only a small proportion of the study
population (approximately 4%). Risk factors for acquisition of
some of the NTDs (often chronic diseases) in VFRs may be due to
exposure during more recent travel or may be related to exposure
years previously before migration took place. Acquisition of other
NTDs (such as T. cruzi infection which is very rarely diagnosed in
travelers) is more likely to have occurred before migration than
during VFR travel. VFRs have been shown to have an increased
risk of acquiring infections during travel [11], and in this study
NTDs were found to be significantly more frequent in VFR
travelers compared to other travelers (but less frequent than in
immigrants). However, further research on NTDs in VFR
travelers would be of value and comparisons should be interpreted
with caution.
An important difference was the large number of immigrants
infected with O. volvulus, which was diagnosed infrequently in
travelers. Most of the patients diagnosed with onchocerciasis were
from Equatorial Guinea, which achieved independence from
Spain in the 1960s. These historical links between both countries
explain the large number of patients from E. Guinea, an area
highly endemic for onchocerciasis, and therefore the high number
of O. volvulus infections. Differences may arise due to the length/
type of exposure necessary for acquisition of some infections, as
these conditions are achieved more readily by the local population
in endemic areas. However, with the recent changes in travel
patterns, not only quantity but also quality of travel becomes an
issue, as more people visit remote and exotic destinations. As
occurred for some cases in this study, several case reports describe
only short durations of exposure for filarial-infected travelers and
risks may be linked to the lack of preventive measures and specific
exposure in vector habitats [12,13]. In future, more travelers may
present to health centers in areas of the western world with
filariasis.
On the other hand, most cases of schistosomiasis were
diagnosed in travelers and this may be partly due to the presence
of semi-immunity in adult immigrants from endemic areas. In
communities where Schistosoma species are endemic, prevalence
and intensity of schistosomiasis have been found to be higher in
children whereas some adults may generate certain protective
responses [14,15]. These protective mechanisms following expo-
sure would not be expected to have developed in travelers,
especially following only short-term exposure.
Other NTDs, such as dracunculiasis, Buruli ulcer and African
and American trypanosomiasis are very infrequent in travelers,
with only very few cases reported in the literature [16–19], and
these diseases were not diagnosed in this cohort either.
The absence of NTDs such as dracunculiasis even in the cohort
of immigrants may reflect the decrease in incidence world wide
which may be attributed to the progress of the global
dracunculiasis eradication program [20]. The Global Program to
Eliminate Lymphatic Filariasis has also had an important impact
in communities in Africa and Asia [21]. An example of the success
of another of these programs could be illustrated by the findings in
this study, which showed a significant decrease in cases of
onchocerciasis in recent years, despite the increasing number of
patients attended at the unit. The Onchocerciasis Control
Program in West Africa focusing on vector control and the
Ivermectin donation program established in 1987, have increased
general interest in health-related public-private partnerships
[22,23]. The results presented in this analysis may reflect how
Imported Neglected Tropical Diseases
www.plosntds.org 6 July 2010 | Volume 4 | Issue 7 | e762the implementation of such programs in an endemic developing
country may have more widespread effects by changing the
presentation and epidemiology of the disease in a non-endemic
country.
Once NTDs are imported into non-endemic areas, the
possibility of transmission and the resulting impact should be
considered. In general, the epidemiology of infectious diseases will
be influenced by the interactions between pathogen, host (human,
animal or vector) and the environment [24], and most of these
infections will have only limited transmission as the required
vector may be absent and the environmental conditions
unfavorable. However, there have been rising concerns regarding
the emergence of some pathogens due to infectious agents being
imported into novel non-endemic areas and the possibility of
accidental spread of disease vectors between areas which may act
as drivers for the emergence of infections [24]. Local vectors may
become infected with imported infectious agents resulting in local
cases as occurred in the first outbreak of chikungunya virus
infection in a temperate country which was registered in Italy,
where the vector, Aedes albopictus is already established [25]. Similar
outbreaks could theoretically occur in other non-tropical countries
and involving other vectors and other imported infectious
pathogens. The prospect of possible future spread of some of the
NTDs outside their usual geographical areas should therefore not
be dismissed. Global changes in climate and temperatures may
affect the distribution of vectors and trigger disease outbreaks and
the possibility of non-vectorial transmission also emerges [24,26].
Chagas disease, paradoxically, is an NTD with a reported
decreasing health and economic impact in endemic countries due
to the success of multi-national control programs aimed principally
at the interruption of vectorial and transfusional transmission [27],
but the disease now appears to be emerging outside these areas
[28]. In Europe, and especially in Spain, cases of Chagas disease
have been increasing due to the recent increase in immigration
from Latin America and the disease may become an important
cause of cardiomyopathy in the near future [28]. Tainted donor
blood or organ grafts and vertical transmission would be the main
modes of transmission of Trypanosoma cruzi imported by immigrants
in countries where vectorial transmission does not occur. This
growth in immigration has had sufficient impact to warrant
changes in national legislation with respect to the screening of
blood donations [29], and yet pregnant Latin American women
are not always screened for Trypanosoma cruzi infection. Specific
preventive strategies would need to be developed and implement-
ed at a national level in order to control non-vectorial transmission
outside endemic areas.
Health professionals attending immigrants and travelers from
tropical countries should consider protocols for screening and
prevention of NTDs in their everyday practice. Regarding pre-
travel advice, for travelers and especially VFRs, adherence to a few
basic precautions, (safe consumption of food/water, protection
against arthropod bites and avoiding swimming in fresh water/
walking barefoot) could help prevent the majority of NTDs.
Early detection of cases may permit prevention of secondary
transmission.
The control of NTDs in endemic areas with low-cost effective
interventions such as rapid-impact packages, may lead to long-
term economic growth given the reported high return rates on
investments in these diseases [1,21,30,31]. Recognising that
certain NTDs may also have an impact in areas of the western
world should help create unique opportunities for research and
control measures in countries with greater means. Studies in non-
endemic areas may provide valuable data as patients will not
ordinarily be re-infected unless they travel to endemic countries
again.
Hopefully the problem of the neglected tropical diseases
‘‘spilling over’’ into more developed countries will be linked to
even greater combined international efforts to control these
infections.
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